Methylene diphosphonate
From Wikipedia, the free encyclopedia
|
Methylene diphosphonate
|
|
| Systematic (IUPAC) name | |
| phosphonomethylphosphonic acid | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | CH6O6P2 |
| Mol. mass | 176.002 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Methylene diphosphonate (MDP or medronic acid) is a pharmaceutical product used especially in nuclear medicine, linked to 99mTc, as a marker to avoid the Single Photon Emission Scintigraphy, or SPECT, to localize carcinogentic bone metastasis as well as other diseases that can alter the natural turn-over in bone.
|
|||||||||||

